Concepedia

Jing-Yi Chung

JC

Statistics

Publications

5

Citations

1.1K

H-Index

5

Active since

2019

Affiliations

University of California, Berkeley(Current)

Chan Zuckerberg Initiative (United States)

Parker Institute for Cancer Immunotherapy

UCSF Helen Diller Family Comprehensive Cancer Center

Gladstone Institutes

Jing-Yi Chung is an author at University of California, Berkeley specializing in life sciences, biotechnology, and crispr-cas systems.

ORCID

Publications per year

2019–2023

5

Publications

5

Detection of unamplified target genes via CRISPR–Cas9 immobilized on a graphene field-effect transistor

Reza Hajian, Sarah Balderston, Thanhtra P. Tran et al. · Nature Biomedical Engineering · 2019 · 640 citations

, , +7

High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails

Brian R. Shy, Vivasvan S. Vykunta, Alvin Ha et al. · Nature Biotechnology · 2022 · 222 citations · Full text

, , +14

Interferon-independent STING signaling promotes resistance to HSV-1 in vivo

Lívia H. Yamashiro, Stephen C. Wilson, Huntly M. Morrison et al. · Nature Communications · 2020 · 174 citations · Full text

, , +17

An evolved AAV variant enables efficient genetic engineering of murine T cells

William A. Nyberg, Jonathan Ark, Angela To et al. · Cell · 2023 · 95 citations · Full text

, , +17

Hybrid ssDNA repair templates enable high yield genome engineering in primary cells for disease modeling and cell therapy manufacturing

Brian R. Shy, Vivasvan S. Vykunta, Alvin Ha et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 16 citations · Full text

, , +17

1–5 of 5